Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ernst, CA

Barron R. Ernst, San Francisco, CA US

Patent application numberDescriptionPublished
20100100402METHOD AND SYSTEM FOR DETERMINING AND SETTING ENVIRONMENTAL IMPACT RELATED PRICE POINTS - A system and method for price setting based on environmental impact whereby the environmental impact of a product and/or service is determined based on defined parameters. An environmental impact of a given product and/or service is also determined for various levels of consumption of the given product and/or service. An environmental impact goal is then established for the given product and/or service. An environmental impact goal level of consumption of the given product and/or service is then determined that will yield the desired environmental impact goal. An environmental impact goal price-point for the given product and/or service that will yield the environmental impact goal level of consumption that, in turn, will yield the desired environmental impact goal is then determined. The price of the given product or service is then set at the environmental impact goal price-point for the given product and/or service using one or more of various price setting mechanisms.04-22-2010

Frederick W. Ernst, Los Angeles, CA US

Patent application numberDescriptionPublished
20090017913LOCATION-BASED MULTIPLAYER GAMING PLATFORM - The methods and systems disclosed herein include a gaming platform that may support massively-multiplayer online computer games, with elements of social networking, in which players may use mobile devices in order to verify their location and claim a measure of control over the location. Players may function like game pieces in association with other members on a team and participate in competitions to capture and defend real-world territory as part of the gaming experience. The gaming platform and associated entities may share revenue and other incentives with entities associated with the locations controlled by the players on the game platform.01-15-2009

James Ernst, San Francisco, CA US

Patent application numberDescriptionPublished
20110256127ANTI-LRP6 ANTIBODIES - The invention provides anti-LRP6 antibodies and methods of using the same. A particular aspect of the invention provides for bispecific anti-LRP6 antibodies that inhibit signaling by multiple Wnt isoforms.10-20-2011

James A. Ernst, San Francisco, CA US

Patent application numberDescriptionPublished
20080299136WNT ANTAGONISTS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF WNT-MEDIATED DISORDERS - The present invention provides for chimeric Wnt antagonists comprising a Frz domain component derived from a Frizzled protein, a secreted Frizzled related protein or Ror protein and an Fc immunoglobulin component, and their use in the treatment and diagnostic detection of cellular Wnt signaling and Wnt-mediated disorders, including cancer.12-04-2008
20090258410METHODS FOR PRODUCING SOLUBLE MEMBRANE SPANNING PROTEINS - Methods for producing membrane-spanning polypeptides in high yields, with native conformation, and/or in soluble form include solubilizing in non-ionic or zwitterionic detergents, as well as use of promoters and expression vectors for expressing high yields of membrane-spanning polypeptides in bacterial cells. Mutated promoters provide tight control of membrane-spanning polypeptides in bacterial cell hosts.10-15-2009
20100081170METHODS FOR PRODUCING SOLUBLE MEMBRANE-SPANNING PROTEINS - Methods for producing membrane-spanning polypeptides in high yields, with native conformation, and/or in soluble form include solubilizing in non-ionic or zwitterionic detergents, as well as use of promoters and expression vectors for expressing high yields of membrane-spanning polypeptides in bacterial cells. Mutated promoters provide tight control of membrane-spanning polypeptides in bacterial cell hosts.04-01-2010
20100266593WNT ANTAGONISTS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF WNT-MEDIATED DISORDERS - The present invention provides for chimeric Wnt antagonists comprising a Frz domain component derived from a Frizzled protein, a secreted Frizzled related protein or Ror protein and an Fc immunoglobulin component, and their use in the treatment and diagnostic detection of cellular Wnt signaling and Wnt-mediated disorders, including cancer.10-21-2010
20110250639METHODS FOR PRODUCING SOLUBLE MEMBRANE-SPANNING PROTEINS - Methods for producing membrane-spanning polypeptides in high yields, with native conformation, and/or in soluble form include solubilizing in non-ionic or zwitterionic detergents, as well as use of promoters and expression vectors for expressing high yields of membrane-spanning polypeptides in bacterial cells. Mutated promoters provide tight control of membrane-spanning polypeptides in bacterial cell hosts.10-13-2011

Patent applications by James A. Ernst, San Francisco, CA US

Johannes Ernst, Sunnyvale, CA US

Patent application numberDescriptionPublished
20090013391Identification System and Method - A system and a method is disclosed for securely identifying human and non-human actors. A computer implemented system and a method is also disclosed for securely identifying human and non-human actors.01-08-2009

Justin Ernst, San Diego, CA US

Patent application numberDescriptionPublished
20100093734CYTOKINE INHIBITORS - The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines such as arthritis.04-15-2010
20100093735CYTOKINE INHIBITORS - The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines such as arthritis.04-15-2010
20100273797ALPHA-KETOAMIDES AND DERIVATIVES THEREOF - The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions medicated by cytokines such as arthritis.10-28-2010